
<style>
    * {
        box-sizing: border-box !important;
    }

    body {
        font-family: 'Inter', 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif !important;
        line-height: 1.9 !important;
        color: #1f1f1f !important;
        max-width: none !important;
        margin: 0 !important;
        padding: 8px 16px 16px 16px !important;
        background: #ffffff !important;
        font-size: 16.5px !important;
    }

    p {
        margin-bottom: 20px !important;
        font-size: 16.5px !important;
        line-height: 1.95 !important;
        color: #1f1f1f !important;
        font-weight: 400 !important;
    }

    strong, b {
        color: #1a73e8 !important;
        font-weight: 700 !important;
        background: rgba(26, 115, 232, 0.08) !important;
        padding: 2px 6px !important;
        border-radius: 8px !important;
    }

    /* Details/Summary (collapsible sections) */
    details {
        background: linear-gradient(135deg, #f8f9fa 0%, #ffffff 100%) !important;
        border-radius: 8px !important;
        padding: 24px 28px !important;
        margin: 24px 0 !important;
        border: none;
        box-shadow: none !important;
        transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1) !important;
    }

    details:hover {
        border-color: #1a73e8 !important;
        box-shadow: none !important;
        transform: translateY(-2px) !important;
    }

    details[open] {
        background: #ffffff !important;
        border-color: #1a73e8 !important;
        box-shadow: none !important;
    }

    summary {
        cursor: pointer !important;
        font-weight: 800 !important;
        color: #ffffff !important;
        font-size: 20px !important;
        padding: 16px 24px !important;
        border-radius: 8px !important;
        background: linear-gradient(135deg, #1a73e8 0%, #1557b0 100%) !important;
        transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1) !important;
        display: flex !important;
        align-items: center !important;
        user-select: none !important;
        box-shadow: none !important;
        letter-spacing: 0.5px !important;
    }

    summary:hover {
        background: linear-gradient(135deg, #1557b0 0%, #0d47a1 100%) !important;
        transform: translateX(6px) scale(1.02) !important;
        box-shadow: none !important;
    }

    summary:active {
        transform: translateX(4px) scale(0.99) !important;
    }

    summary::marker {
        color: rgba(255, 255, 255, 0.9) !important;
        font-size: 1.3em !important;
    }

    summary strong {
        background: rgba(255, 255, 255, 0.2) !important;
        color: #ffffff !important;
        padding: 4px 12px !important;
        border-radius: 8px !important;
        margin-left: 8px !important;
        font-size: 19px !important;
        letter-spacing: 1px !important;
    }

    /* Tables - Premium Design */
    table {
        width: 100% !important;
        border-collapse: separate !important;
        border-spacing: 0 !important;
        margin: 28px 0 !important;
        border-radius: 8px !important;
        overflow: hidden !important;
        box-shadow: none !important;
        border: none !important;
        background: #ffffff !important;
    }

    table.simple-table {
        background: linear-gradient(135deg, #ffffff 0%, #f8f9fa 100%) !important;
    }

    table tr {
        transition: all 0.25s cubic-bezier(0.4, 0, 0.2, 1) !important;
        position: relative !important;
    }

    table tr:nth-child(odd) {
        background: rgba(248, 249, 250, 0.5) !important;
    }

    table tr:nth-child(even) {
        background: rgba(255, 255, 255, 0.8) !important;
    }

    table tr:hover {
        background: linear-gradient(90deg, #e8f0fe 0%, #f1f8ff 100%) !important;
        transform: translateX(4px) scale(1.01) !important;
        box-shadow: none !important;
        z-index: 1 !important;
    }

    table td {
        padding: 18px 24px !important;
        border-bottom: 1px solid rgba(232, 234, 237, 0.6) !important;
        font-size: 16.5px !important;
        line-height: 1.7 !important;
        color: #1f1f1f !important;
        vertical-align: middle !important;
    }

    table tr:last-child td {
        border-bottom: none !important;
    }

    /* First column (A, B, C, D, E) */
    table td:first-child {
        font-weight: 800 !important;
        color: #ffffff !important;
        width: 52px !important;
        text-align: center !important;
        font-size: 18px !important;
        background: linear-gradient(135deg, #1a73e8 0%, #1557b0 100%) !important;
        border-right: 3px solid #1557b0 !important;
        position: relative !important;
        letter-spacing: 0.5px !important;
    }

    table tr:hover td:first-child {
        background: linear-gradient(135deg, #1557b0 0%, #0d47a1 100%) !important;
        box-shadow: none !important;
    }

    /* Second column (content) */
    table td:nth-child(2) {
        font-weight: 500 !important;
        padding-left: 28px !important;
    }

    /* Third column (empty - hide it) */
    table td:last-child:empty {
        display: none !important;
    }

    /* Lists */
    ul, ol {
        margin: 16px 0 !important;
        padding-left: 32px !important;
    }

    li {
        margin: 10px 0 !important;
        line-height: 1.8 !important;
        color: #1f1f1f !important;
    }

    ul.bulleted-list li {
        position: relative !important;
        padding-left: 8px !important;
    }

    ul.toggle {
        list-style: none !important;
        padding-left: 0 !important;
    }

    /* Links */
    a {
        color: #1a73e8 !important;
        text-decoration: none !important;
        font-weight: 600 !important;
        border-bottom: 2px solid transparent !important;
        transition: all 0.2s !important;
    }

    a:hover {
        border-bottom-color: #1a73e8 !important;
        background: rgba(26,115,232,0.08) !important;
        padding: 2px 4px !important;
        border-radius: 8px !important;
    }

    /* Images & Media */
    img, video {
        max-width: none !important;
        height: auto !important;
        border-radius: 8px !important;
        box-shadow: none !important;
        margin: 24px 0 !important;
        display: block !important;
        border: none !important;
    }

    img:hover, video:hover {
        box-shadow: none !important;
        border-color: #1a73e8 !important;
    }

    /* Code blocks (if any) */
    code {
        background: #f1f3f4 !important;
        padding: 2px 8px !important;
        border-radius: 8px !important;
        font-family: 'Courier New', monospace !important;
        font-size: 14px !important;
        color: #d93025 !important;
    }

    pre {
        background: #f8f9fa !important;
        padding: 8px 16px 16px 16px !important;
        border-radius: 8px !important;
        overflow-x: auto !important;
        border-left: 4px solid #1a73e8 !important;
    }

    /* Headings */
    h1, h2, h3, h4, h5, h6 {
        color: #1a73e8 !important;
        font-weight: 700 !important;
        margin-top: 24px !important;
        margin-bottom: 16px !important;
        line-height: 1.4 !important;
    }

    h1 { font-size: 32px !important; }
    h2 { font-size: 26px !important; }
    h3 { font-size: 22px !important; }
    h4 { font-size: 19px !important; }

    /* Blockquotes */
    blockquote {
        border-left: 4px solid #1a73e8 !important;
        padding-left: 20px !important;
        margin: 20px 0 !important;
        font-style: italic !important;
        color: #5f6368 !important;
        background: #f8f9fa !important;
        padding: 16px 20px !important;
        border-radius: 8px !important;
    }

    /* Horizontal Rule */
    hr {
        border: none !important;
        height: 2px !important;
        background: linear-gradient(to right, transparent, #1a73e8, transparent) !important;
        margin: 32px 0 !important;
    }

    /* Selection */
    ::selection {
        background: #e8f0fe !important;
        color: #1a73e8 !important;
    }

    /* Highlighter styles */
    .highlighted {
        background-color: #ffeb3b !important;
        transition: background-color 0.2s ease !important;
    }

    .highlighter-btn {
        background: none !important;
        border: none !important;
        cursor: pointer !important;
        font-size: 20px !important;
        padding: 0 8px !important;
        margin-left: 8px !important;
        transition: transform 0.2s ease !important;
        vertical-align: middle !important;
    }

    .highlighter-btn:hover {
        transform: scale(1.2) !important;
    }

    .highlighter-btn.active {
        transform: scale(1.1) !important;
        filter: brightness(1.2) !important;
    }

    .highlighter-mode-active {
        cursor: text !important;
    }


    /* Right padding to avoid overlap with sidebar buttons */
    body {
        padding-right: 50px !important;
    }

    @media (max-width: 768px) {
        body {
            padding-right: 16px !important;
        }
    }

</style>




<details open>
<summary><strong>8523</strong><button class="bionic-reading-btn" onclick="toggleBionicReading(event)" title="Toggle Bionic Reading (Ctrl+B)"><span id="bionicIcon">üëÅÔ∏è</span></button><button class="highlighter-btn" onclick="toggleHighlighter(event)" title="Toggle Highlighter (Ctrl+H)"><span id="highlighterIcon">üñäÔ∏è</span></button></summary>
<p class="" id="e6439909-045c-4c38-941e-bc7f50045f39">A 34-year-old woman comes to
                                        the physician for a follow-up visit.  She was diagnosed with rheumatoid
                                        arthritis 3 months ago and started on methotrexate therapy.  Despite treatment,
                                        she continues to have several hours of morning stiffness daily and frequently
                                        awakens at night due to joint pain.  Physical examination shows swelling and
                                        tenderness in the joints of her hands and wrists.  Etanercept is subsequently
                                        added to her treatment regimen.  This medication is best characterized as which
                                        of the following?</p>
<table class="simple-table" id="dc22ef99-3b23-4b47-95fa-05978bed5183">
<tbody>
<tr id="49609594-7087-4d21-a28f-ba6fd34a7fb1">
<td class="" id="]cF_">A.</td>
<td class="" id="aNIr">Cell surface receptor antibody</td>
<td class="" id="\FW~"></td>
</tr>
<tr id="6708f929-8cee-4ca3-b94d-ac02209f7f87">
<td class="" id="]cF_">B.</td>
<td class="" id="aNIr">Chimeric monoclonal antibody</td>
<td class="" id="\FW~"></td>
</tr>
<tr id="a0729faf-7197-48e0-91c0-93e064c376ad">
<td class="" id="]cF_">C.</td>
<td class="" id="aNIr">Humanized monoclonal antibody</td>
<td class="" id="\FW~"></td>
</tr>
<tr id="c2c747f1-5bdc-4da0-a96d-03fc73a26ff1">
<td class="" id="]cF_">D.</td>
<td class="" id="aNIr">Small-molecule receptor inhibitor</td>
<td class="" id="\FW~"></td>
</tr>
<tr id="0f9316d2-9106-431a-9422-9d7812274c9b">
<td class="" id="]cF_">E.</td>
<td class="" id="aNIr">Soluble receptor decoy protein</td>
<td class="" id="\FW~"></td>
</tr>
</tbody>
</table>
<ul class="toggle" id="fd50425f-251e-46a1-bc41-5be88d3b7ad9">
<li>
<details>
<summary>Submit</summary>
<table class="simple-table" id="74491e82-4bc3-47c8-ba45-19ccaa72684c">
<tbody>
<tr id="b669d1c0-3142-4317-8793-93819e80631e">
<td class="" id="&gt;ayM">A.</td>
<td class="" id="I|ui">Cell surface receptor antibody (13%)
                                                            </td>
<td class="" id="Vbwg"></td>
</tr>
<tr id="628b8e5b-18b9-41ff-b2ac-d94507958b0b">
<td class="" id="&gt;ayM">B.</td>
<td class="" id="I|ui">Chimeric monoclonal antibody (13%)
                                                            </td>
<td class="" id="Vbwg"></td>
</tr>
<tr id="ed1a4762-228a-4946-b31b-c9b488f34c21">
<td class="" id="&gt;ayM">C.</td>
<td class="" id="I|ui">Humanized monoclonal antibody (12%)
                                                            </td>
<td class="" id="Vbwg"></td>
</tr>
<tr id="6ed4b322-b275-48ba-a486-4ebf4e22a036">
<td class="" id="&gt;ayM">D.</td>
<td class="" id="I|ui">Small-molecule receptor inhibitor
                                                                (14%)</td>
<td class="" id="Vbwg"></td>
</tr>
<tr id="d54a4133-1fcf-4796-8b28-27b47691c4c3">
<td class="" id="&gt;ayM">E.</td>
<td class="" id="I|ui">Soluble receptor decoy protein (46%)
                                                            </td>
<td class="" id="Vbwg"></td>
</tr>
</tbody>
</table>
<p class="" id="73ec8e07-1c0a-4bf1-97c5-1c331d5a517a">Incorrect</p>
<p class="" id="64a4006e-98f4-451a-85e5-de3db4ef0804">Correct answer E
                                                </p>
<p class="" id="70ad933a-fe80-4087-ad5c-d97b813df553">46%Answered
                                                    correctly</p>
<p class="" id="dacad5d7-1284-4684-a13e-64fd0a683d1c">11 secsTime Spent
                                                </p>
<p class="" id="b4737adc-dbfc-41fe-9b15-c929e9bafb50">2024Version</p>
<ul class="bulleted-list" id="5e7cf5d0-8e55-4275-953b-880d6060d748">
<li style="list-style-type:disc">Explanation</li>
</ul>
<ul class="bulleted-list" id="e6aecdc0-ae78-40b3-bb46-818065dab855">
<li style="list-style-type:disc"></li>
</ul>
<figure class="image" id="efbce9f9-56cd-4e5a-9df9-20b9631ac76f"><a href="https://www.uworld.com/media/L10503.jpg"><img loading="lazy" src="https://www.uworld.com/media/L10503.jpg" style="width:700px"/></a>
</figure>
<p class="" id="771e98e5-640c-4afd-bf5d-255188fdafa4">Etanercept is a
                                                    tumor necrosis factor-alpha (TNF-Œ±) inhibitor added to methotrexate
                                                    to treat moderate-to- severe rheumatoid arthritis in patients who
                                                    have failed methotrexate alone.  It is a fusion protein linking a
                                                    soluble TNF-Œ± receptor to the Fc component of human immunoglobulin
                                                    G1 (IgG1).  Etanercept reduces the biological activity of TNF-Œ± by
                                                    acting as a decoy receptor: the TNF-Œ± receptor component acts like a
                                                    sponge to bind TNF-Œ± and keep it away from functional TNF-Œ±
                                                    receptors, while the Fc component stabilizes the complex.</p>
<p class="" id="e04635e9-5735-4a9b-9dba-e4feb1db9217">Pharmaceutical
                                                    companies provide the prefix of the names for biological agents; the
                                                    suffix indicates whether the medication is a monoclonal antibody
                                                    (<em>mab</em>), a receptor molecule (<em>cept</em>), or a kinase
                                                    inhibitor (<em>nib</em>).  Monoclonal antibodies, which are the
                                                    largest group of biological agents, also include in their names the
                                                    type of target (eg, bacterial or immune system) and their origin
                                                    (eg, human or mouse).</p>
<p class="" id="0c614167-b815-47e9-b64b-e31b3985efc7">(Choice A) 
                                                    Rituximab (Ri-tu-xi-mab) is a chimeric monoclonal antibody targeted
                                                    against CD20, a cell receptor found on the surface of B cells.  It
                                                    is used to treat CD20+ non-Hodgkin's lymphomas and other
                                                    diseases related to excessive B-cell function.</p>
<p class="" id="3946a3c7-ecbf-4a97-9348-8d126f5927b2">(Choice B) 
                                                    Infliximab (Inf-li-xi-mab) is a chimeric monoclonal antibody
                                                    targeted against TNF-Œ±.  It is used in the treatment of a number of
                                                    autoimmune diseases (eg, rheumatoid arthritis and Crohn's
                                                    disease).</p>
<p class="" id="1848f747-3546-438c-93e1-bc8dc9f955d4">(Choice C) 
                                                    Certolizumab pegol (Certo-li-zu-mab) is a pegylated (pegol)
                                                    humanized monoclonal antibody that targets TNF-Œ±.  It lacks the Fc
                                                    region, which helps minimizes complement activation and
                                                    cell-mediated cytotoxicity that can occur with other anti-TNF-Œ±
                                                    medications that contain Fc domains.</p>
<p class="" id="4d3b8de6-1806-4ebf-9579-9738f20c1354">(Choice D) 
                                                    Imatinib (Imati-nib) mesylate is used to treat specific cancers,
                                                    including Philadelphia chromosome-positive chronic myelogenous
                                                    leukemia and kit-positive gastrointestinal stromal tumors.  It is an
                                                    example of a small-molecule tyrosine kinase receptor inhibitor.</p>
<p class="" id="b8f3d63d-e410-4fd7-8460-a0de243db12b">Educational
                                                    objective:</p>
<p class="" id="0212a89f-f81b-48ac-b18e-1909c56c9728">The suffix of a
                                                    biological agent indicates whether a medication is a monoclonal
                                                    antibody (<em>mab</em>), a receptor molecule (<em>cept</em>), or a
                                                    kinase inhibitor (<em>nib</em>).  Monoclonal antibodies also include
                                                    in their names the type of target (eg, bacterial or immune system)
                                                    and their origin (eg, human or mouse).</p>
<p class="" id="dbd9820c-733c-45f8-890a-472caaa8e5da">Immunology</p>
<p class="" id="f2bd74e9-709f-418a-8090-ceb798519d53">Subject</p>
<p class="" id="427fd472-8964-4602-a081-610418982e93">Allergy &amp;
                                                    Immunology</p>
<p class="" id="9a83b207-b0df-45ec-9633-64f21858554e">System</p>
<p class="" id="687af956-19a0-4bed-8d9b-d6a263b696c8">Drug structure and
                                                    properties</p>
<p class="" id="e3e9a970-9e1f-4d1d-8a98-752ab805d4cc">Topic</p>
<p class="" id="9f3b50f7-b822-4215-8c73-1b4ed4cf34c8">Copyright ¬©
                                                    UWorld. All rights reserved.</p>
</details>
</li>
</ul>
</details>


















<style>
.bionic-reading-btn {
    display: inline-flex;
    align-items: center;
    justify-content: center;
    width: 40px;
    height: 40px;
    background: rgba(255, 255, 255, 0.2);
    border: 2px solid rgba(255, 255, 255, 0.3);
    border-radius: 8px;
    color: white;
    font-size: 20px;
    cursor: pointer;
    transition: all 0.3s;
    margin-left: auto;
    flex-shrink: 0;
}

.bionic-reading-btn:hover {
    background: rgba(255, 255, 255, 0.35);
    border-color: rgba(255, 255, 255, 0.5);
    transform: scale(1.1);
}

.bionic-reading-btn.active {
    background: rgba(52, 168, 83, 0.4);
    border-color: rgba(52, 168, 83, 0.6);
}

.bionic-reading-btn.active:hover {
    background: rgba(52, 168, 83, 0.5);
}

summary {
    display: flex !important;
    align-items: center !important;
    gap: 12px !important;
}

    /* Highlighter styles */
    .highlighted {
        background-color: #ffeb3b !important;
        transition: background-color 0.2s ease !important;
    }

    .highlighter-btn {
        background: none !important;
        border: none !important;
        cursor: pointer !important;
        font-size: 20px !important;
        padding: 0 8px !important;
        margin-left: 8px !important;
        transition: transform 0.2s ease !important;
        vertical-align: middle !important;
    }

    .highlighter-btn:hover {
        transform: scale(1.2) !important;
    }

    .highlighter-btn.active {
        transform: scale(1.1) !important;
        filter: brightness(1.2) !important;
    }

    .highlighter-mode-active {
        cursor: text !important;
    }


    /* Right padding to avoid overlap with sidebar buttons */
    body {
        padding-right: 50px !important;
    }

    @media (max-width: 768px) {
        body {
            padding-right: 16px !important;
        }
    }

</style>



<script>
let bionicEnabled = false;
const originalContent = {};

function toggleBionicReading(event) {
    if (event) {
        event.preventDefault();
        event.stopPropagation();
    }

    bionicEnabled = !bionicEnabled;
    const btn = document.querySelector('.bionic-reading-btn');
    const icon = document.getElementById('bionicIcon');

    if (bionicEnabled) {
        btn.classList.add('active');
        icon.textContent = '‚úÖ';
        applyBionicReading();
    } else {
        btn.classList.remove('active');
        icon.textContent = 'üëÅÔ∏è';
        restoreOriginalText();
    }
}

function applyBionicReading() {
    // Seleciona todos os elementos de texto, EXCETO summary e buttons
    const textElements = document.querySelectorAll('p:not(summary p):not(button p), td:not(summary td):not(button td), li:not(summary li):not(button li)');

    textElements.forEach((element, index) => {
        // Ignora elementos que cont√™m outros elementos complexos
        if (element.querySelector('p, td, li, h1, h2, h3, h4, h5, h6, button, summary')) {
            return;
        }

        // Ignora se o elemento est√° dentro de um summary ou button
        if (element.closest('summary') || element.closest('button') || element.closest('.bionic-reading-btn')) {
            return;
        }

        // Salva o conte√∫do original
        if (!originalContent[index]) {
            originalContent[index] = {
                element: element,
                html: element.innerHTML
            };
        }

        // Aplica Bionic Reading
        const bionicText = convertToBionic(element.textContent);
        element.innerHTML = bionicText;
    });
}

function restoreOriginalText() {
    // Restaura o conte√∫do original
    Object.values(originalContent).forEach(item => {
        item.element.innerHTML = item.html;
    });
}

function convertToBionic(text) {
    // Divide o texto em palavras, mantendo pontua√ß√£o
    const words = text.split(/(\s+|[.,;:!?()""''\-‚Äì‚Äî])/);

    const bionicWords = words.map(word => {
        // Ignora espa√ßos e pontua√ß√£o
        if (word.match(/^\s+$/) || word.match(/^[.,;:!?()""''\-‚Äì‚Äî]+$/)) {
            return word;
        }

        // Ignora palavras muito curtas (1-2 letras)
        if (word.length <= 2) {
            return word;
        }

        // Determina quantas letras deixar em negrito (metade da palavra, arredondado para cima)
        const boldLength = Math.ceil(word.length / 2);

        // Separa a parte em negrito da parte normal
        const boldPart = word.substring(0, boldLength);
        const normalPart = word.substring(boldLength);

        // Retorna com a primeira parte em negrito
        return `<strong style="font-weight: 700 !important; color: inherit !important; background: none !important; padding: 0 !important;">${boldPart}</strong>${normalPart}`;
    });

    return bionicWords.join('');
}

// Adiciona atalho de teclado (Ctrl+B ou Cmd+B)
document.addEventListener('keydown', function(e) {
    if ((e.ctrlKey || e.metaKey) && e.key === 'b') {
        e.preventDefault();
        toggleBionicReading();
    }
});
</script>

<script>
    let highlighterActive = false;
    let questionHighlights = {};

    // Get question ID from the first summary strong tag
    function getQuestionId() {
        const firstSummary = document.querySelector('summary strong');
        return firstSummary ? firstSummary.textContent.trim() : '1';
    }

    // Load highlights from localStorage
    function loadHighlights() {
        const questionId = getQuestionId();
        const stored = localStorage.getItem('highlights_' + questionId);
        if (stored) {
            questionHighlights = JSON.parse(stored);
            applyStoredHighlights();
        }
    }

    // Save highlights to localStorage
    function saveHighlights() {
        const questionId = getQuestionId();
        localStorage.setItem('highlights_' + questionId, JSON.stringify(questionHighlights));
    }

    // Apply stored highlights
    function applyStoredHighlights() {
        Object.keys(questionHighlights).forEach(key => {
            const element = document.querySelector(`[data-highlight-id="${key}"]`);
            if (element && questionHighlights[key]) {
                element.classList.add('highlighted');
            }
        });
    }

    // Toggle highlighter mode
    function toggleHighlighter(event) {
        event.stopPropagation();
        highlighterActive = !highlighterActive;

        const btn = event.target.closest('.highlighter-btn');
        const icon = btn.querySelector('#highlighterIcon');

        if (highlighterActive) {
            btn.classList.add('active');
            icon.textContent = 'üñçÔ∏è';
            document.body.classList.add('highlighter-mode-active');
        } else {
            btn.classList.remove('active');
            icon.textContent = 'üñäÔ∏è';
            document.body.classList.remove('highlighter-mode-active');
        }
    }

    // Clear all highlights for this question
    function clearHighlights() {
        const questionId = getQuestionId();
        questionHighlights = {};
        localStorage.removeItem('highlights_' + questionId);
        document.querySelectorAll('.highlighted').forEach(el => {
            el.classList.remove('highlighted');
        });
    }

    // Handle text selection and highlighting
    document.addEventListener('mouseup', function(e) {
        if (!highlighterActive) return;

        const selection = window.getSelection();
        if (!selection.toString().trim()) return;

        const range = selection.getRangeAt(0);
        const container = range.commonAncestorContainer;

        // Only highlight text in paragraphs, not in buttons or other elements
        const paragraph = container.nodeType === 3 ? container.parentElement : container;
        if (paragraph.tagName !== 'P' && paragraph.tagName !== 'LI' && paragraph.tagName !== 'TD') {
            return;
        }

        // Create highlight span
        const span = document.createElement('span');
        span.classList.add('highlighted');

        // Generate unique ID for this highlight
        const highlightId = 'hl-' + Date.now() + '-' + Math.random().toString(36).substr(2, 9);
        span.setAttribute('data-highlight-id', highlightId);

        try {
            range.surroundContents(span);
            questionHighlights[highlightId] = true;
            saveHighlights();
        } catch (e) {
            console.log('Could not highlight selection');
        }

        selection.removeAllRanges();
    });

    // Load highlights when page loads
    window.addEventListener('load', loadHighlights);

    // Keyboard shortcut: Ctrl+H to toggle highlighter
    document.addEventListener('keydown', function(e) {
        if (e.ctrlKey && e.key === 'h') {
            e.preventDefault();
            const btn = document.querySelector('.highlighter-btn');
            if (btn) {
                toggleHighlighter({target: btn, stopPropagation: () => {}});
            }
        }
        // Ctrl+Shift+H to clear all highlights
        if (e.ctrlKey && e.shiftKey && e.key === 'H') {
            e.preventDefault();
            if (confirm('Clear all highlights for this question?')) {
                clearHighlights();
            }
        }
    });
</script>
